180 Life Sciences Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Expense Reimbursement Agreement (Details)

Expense Reimbursement Agreement (Details) - USD ($)		3 Months Ended
Expense Reimbursement Agreement (Details) - USD ($)	Mar. 15, 2019	Mar. 31, 2019	Mar. 31, 2018
Expense Reimbursement Agreement (Textual)
Expense due under reimbursement agreement		$ 49,771
Convertible Promissory Note [Member]
Expense Reimbursement Agreement (Textual)
Related party transaction, description	(i) the consummation of a Business Combination or (ii) the liquidation of the Company. Up to $1,000,000 of the loans under the Promissory Note may be converted, at the Sponsor's discretion, into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Units.
Expense due under reimbursement agreement		$ 49,771
KBL Healthcare Management, LLC [Member] \| Sponsor [Member]
Expense Reimbursement Agreement (Textual)
Related party transaction, description	(i) the consummation of a Business Combination or (ii) the Company's liquidation. Under the Expense Reimbursement Agreement, the Company will reimburse the Sponsor for the compensation expense incurred by KBL Management for its employee in the amount of $180,000 per year plus health insurance costs of $1,139 per month.

- Definition

A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.

+ References + Details